Stocks and InvestingStocks and Investing
Mon, February 5, 2018
Fri, February 2, 2018
Thu, February 1, 2018
Wed, January 31, 2018
Tue, January 30, 2018

Amit Hazan Maintained (ABT) at Hold with Increased Target to $64 on, Jan 30th, 2018


Published on 2024-10-26 02:21:17 - WOPRAI, Amit Hazan
  Print publication without navigation


Amit Hazan of Citigroup, Maintained "Abbott Laboratories" (ABT) at Hold with Increased Target from $59 to $64 on, Jan 30th, 2018.

Amit has made no other calls on ABT in the last 4 months.



There are 9 other peers that have a rating on ABT. Out of the 9 peers that are also analyzing ABT, 1 agrees with Amit's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Sean Lavin of "BTIG" Downgraded from Strong Buy to Hold on, Monday, January 22nd, 2018


These are the ratings of the 8 analyists that currently disagree with Amit


  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $70 on, Thursday, January 25th, 2018
  • Joanne Wuensch of "BMO Capital" Maintained at Buy with Increased Target to $70 on, Thursday, January 25th, 2018
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $70 on, Thursday, January 25th, 2018
  • Margaret Kaczor of "William Blair" Upgraded from Hold to Buy on, Thursday, January 25th, 2018
  • Matthew Taylor of "Barclays" Maintained at Buy with Increased Target to $70 on, Thursday, January 25th, 2018
  • Michael Weinstein of "JP Morgan" Maintained at Buy with Increased Target to $69 on, Thursday, January 25th, 2018
  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $71 on, Thursday, January 25th, 2018
  • Vijay Kumar of "Evercore ISI Group" Initiated at Buy and Held Target at $64 on, Wednesday, January 3rd, 2018